Centre Launches National Drug Registry to Standardise Medicine Information Across India
The Union Government has launched the National Drug Registry, a centralized digital database designed to provide a single, authenticated source of information on medicines used across India’s...
The Union Government has launched the National Drug Registry, a centralized digital database designed to provide a single, authenticated source of information on medicines used across India’s healthcare system. The initiative aims to standardise drug information, improve patient safety and support hospitals, pharmacies, healthcare professionals and digital health platforms with accurate and verified medicine data.
The registry assigns every approved medicine a unique digital identity, creating a uniform reference system for drug names, formulations, strengths and manufacturers. Health authorities believe this will minimise confusion arising from inconsistent drug information while improving prescribing practices and medicine management across healthcare facilities.
Medical experts say a unified drug database will help doctors prescribe medicines more accurately, pharmacists dispense the correct products and patients better understand the medications they receive. The system is also expected to support electronic prescriptions, hospital information systems and digital healthcare applications by ensuring consistent medicine records.
The National Drug Registry forms part of India’s broader digital health transformation, complementing initiatives such as the Ayushman Bharat Digital Mission (ABDM) and electronic health records. Standardised medicine data will enable better interoperability between healthcare providers, improving continuity of care and reducing medication-related errors.
Healthcare professionals note that accurate medicine information is essential for patient safety, particularly when managing chronic diseases, multiple prescriptions and emergency treatment. A centralised registry can also strengthen pharmacovigilance by making it easier to monitor adverse drug reactions and improve regulatory oversight.
Industry experts believe the platform will benefit pharmaceutical companies by simplifying data management while helping regulators maintain updated information on approved medicines. It is also expected to improve transparency across the pharmaceutical supply chain and support future digital healthcare innovations.
The initiative reflects the government’s continued focus on modernising healthcare through technology and data standardisation. By creating a single national source of verified medicine information, the registry aims to improve efficiency, reduce errors and strengthen confidence in India’s healthcare ecosystem.



No Comment! Be the first one.